New York/London, 2 January 2020 – Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS), a biotechnology company focusing on the discovery and development of innovative therapeutics for inflammation and oncology indications, announces that on 31 December 2019, Panetta Partners Limited, an entity closely associated with Gabriele Cerrone, Executive Chairman, bought 12,500 ADSs each representing 5 ordinary shares of nominal value 3p each in the capital of the Company at a price of US$2.79 per ADS, as set out below.
The information set out below is provided in accordance with the requirements of Regulation 19(3) of the EU Market Abuse Regulation No 596/2014:
| 1. | Details of PDMR / person closely associated | |||
| a) | Name | Gabriele Cerrone/Panetta Partners Limited | ||
| 2. | Reason for the notification: On market acquisition | |||
| a) | Position / status | Executive Chairman | ||
| b) | Initial notification /amendment | Initial notification | ||
| 3. | Details of the issuer | |||
| a) | Name | Tiziana Life Sciences plc | ||
| b) | LEI | 213800CED47HI8PIOB36 | ||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||
| a) | Description of the financial instrument | ADS representing 5 Ordinary Shares of nominal value 3p each | ||
| b) | Identification code of the Financial Instrument | 88875G101 | ||
| c) | Nature of the transaction | On market acquisition of ordinary shares | ||
| d) | Price(s) and volume(s) |
|
||
| e) | Aggregated information
– Aggregated volume
– Price |
12,500
US$34,875 |
||
| f) | Date of the transaction | 31 December 2019 | ||
| g) | Place of the transaction | NASDAQ | ||
As a result of this transaction Mr Cerrone’s interests in the underlying ordinary shares of the Company increases from 64,255,925 (47.020%) to 64,318,425 (47.066%). Mr Cerrone’s interests in the ordinary shares of the Company are based on a holding of 63,680,404 ordinary shares held by Planwise Limited and voting rights in respect of 638,021 ordinary shares held by Panetta Partners Limited (as shares and via ADSs). Mr Cerrone is considered beneficially interested in the holdings of Panetta Partners Limited and Planwise Limited.
For more information go to http://www.tizianalifesciences.com
Contacts:
| Tiziana Life Sciences plc
Gabriele Cerrone, Chairman and founder |
+44 (0)20 7495 2379 |
| Cairn Financial Advisers LLP (Nominated adviser)
Liam Murray / Jo Turner |
+44 (0)20 7213 0883 |
| Shore Capital (Broker)
Antonio Bossi / Fiona Conroy |
+44 (0)20 7408 4050 |
